Literature DB >> 10406270

Azathioprine in refractory sprue.

A Vaidya1, J Bolanos, C Berkelhammer.   

Abstract

We report a patient with life-threatening refractory sprue who was dependent on high doses of corticosteroids to prevent severe diarrhea, malabsorption, and villous atrophy. Azathioprine allowed tapering of corticosteroids to lower doses, while maintaining remission in histology and in objective measures of malabsorption. Immunosuppressive therapy, however, is not without risks, particularly in patients with associated hypoglobulinemia.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10406270     DOI： 10.1111/j.1572-0241.1999.01241.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


  6 in total

Review 1.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

2.  A severe but reversible refractory sprue.

Authors:  X Dray; F Joly; A Lavergne-Slove; X Treton; Y Bouhnik; B Messing
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 3.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Celiac Disease.

Authors:  Ahmad S. Abdulkarim; Joseph A. Murray
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

5.  The management of refractory coeliac disease.

Authors:  Jeremy Woodward
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

6.  Peripheral Neuropathy and Celiac Disease.

Authors:  Russell L Chin; Norman Latov
Journal:  Curr Treat Options Neurol       Date:  2005-01       Impact factor: 3.972
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.